Agonists and antagonists of the urotensinergic system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9340575
APP PUB NO 20140113872A1
SERIAL NO

14114757

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel urotensin II receptor (UT) agonists and antagonists are described herein. More specifically, novel derivatives of urotensin II-related peptide (URP) are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE490 DE LA COURONNE QUÉBEC G1K 9A9

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chatenet, David Laval, CA 6 3
Fournier, Alain L'lle Bizard, CA 55 1322
Letourneau, Myriam Les Cedres, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00